Pulmonary Rehabilitation in Salt Chambers for Patients With COPD
The Impact of Pulmonary Rehabilitation Conducted in Therapeutic Salt Chambers on the Clinical Status of Patients With Chronic Obstructive Pulmonary Disease (COPD)
1 other identifier
interventional
80
1 country
1
Brief Summary
Title: The Impact of Pulmonary Rehabilitation Conducted in Therapeutic Salt Chambers on the Clinical Condition of Patients with Chronic Obstructive Pulmonary Disease Background and Rationale: Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory disorder that significantly reduces patients' quality of life and functional capacity. In the search for supportive therapeutic strategies, there is growing interest in unconventional therapeutic environments such as therapeutic salt chambers. The underground climate of the "Wieliczka" Salt Mine in Poland - characterized by humidity 60-75%, temperature 12.9-14.5°C, high air purity and ionization - has shown therapeutic potential. However, the clinical effects of pulmonary rehabilitation conducted in such an environment in COPD patients remain insufficiently documented. Study Objective: To evaluate the effect of pulmonary rehabilitation and climatic therapy conducted in underground salt chambers on the clinical condition of patients with stable COPD. Research Question: Does pulmonary rehabilitation conducted in a subterranean salt mine environment offer measurable clinical benefits compared to standard surface-based rehabilitation? Study Design and Methods: This is a randomized, controlled, four-arm interventional study including 80 adult patients with a confirmed diagnosis of COPD according to the GOLD 2025 criteria. Participants will be randomly assigned to one of four groups: Group A: Pulmonary rehabilitation in underground therapeutic salt chambers (physical training + microclimate exposure). Group B: Pulmonary rehabilitation in a surface-level gymnasium (physical training without microclimate exposure). Group C: Passive stay in underground salt chambers (microclimate exposure without physical training). Group D: Health education only (control group, surface level). The intervention program consists of 16 consecutive working days of 3-hour daily sessions. The content of the rehabilitation varies depending on the assigned group and includes general conditioning exercises, respiratory exercises, relaxation training, and health education. Outcome Measures and Assessment Tools: Clinical assessments will be conducted at three time points: prior to the intervention (T0), immediately after the intervention (T1), and at a 3-month follow-up (T2 - for Groups A and B only). The monitored variables include: Exercise Tolerance: Incremental Shuttle Walk Test (ISWT) Health-Related Quality of Life: St. George's Respiratory Questionnaire COPD Symptoms and Risk Indexes: COPD Assessment Test (CAT), BODE Index Muscle Strength: Deadlift test, hand dynamometer, 30-second Chair Stand Test Respiratory Muscle Strength: Maximal Inspiratory Pressure (MIP) and Maximal Expiratory Pressure (MEP) Body Composition: Bioelectrical Impedance Analysis (BIA) Dyspnea Scales: Borg Scale, modified Medical Research Council (mMRC) scale Chest Mobility: Measuring tape assessment The study is designed to evaluate both the immediate and long-term effects of different pulmonary rehabilitation models on clinical outcomes in COPD patients, with a focus on whether the underground environment enhances rehabilitation efficacy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 30, 2025
CompletedFirst Posted
Study publicly available on registry
August 14, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2028
November 26, 2025
July 1, 2025
1.3 years
July 30, 2025
November 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in exercise tolerance (ISWT distance)
Incremental Shuttle Walk Test (ISWT) used to assess functional exercise tolerance in COPD patients. Measured as distance walked in meters. Evaluates change from baseline to post-intervention and at 3-month follow-up to assess immediate and sustained effects of rehabilitation.
Baseline (Day 1), Post-intervention (Day 18), 3 months follow-up (Day 108)
Change in quality of life (SGRQ-C total score)
St. George's Respiratory Questionnaire version COPD (SGRQ-C) measures disease-specific quality of life.
Baseline (Day 1), Post-intervention (Day 18), 3 months follow-up (Day 108)
Secondary Outcomes (6)
Change in Respiratory Muscle Strength
Baseline (Day 1), Post-intervention (Day 18), 3 months follow-up (Day 108)
Change in Chest Mobility
Baseline (Day 1), Post-intervention (Day 18), 3 months follow-up (Day 108)
Change in COPD Symptoms Severity
Baseline (Day 1), Post-intervention (Day 18), 3 months follow-up (Day 108)
Change in Dyspnea Severity
Baseline (Day 1), Post-intervention (Day 18), 3 months follow-up (Day 108)
Change in Muscle Strength
Baseline (Day 1), Post-intervention (Day 18), 3 months follow-up (Day 108)
- +1 more secondary outcomes
Other Outcomes (2)
BODE Index
Baseline (Day 1 only)
Post-Bronchodilator Spirometry
Baseline (Day 1 only)
Study Arms (4)
Pulmonary Rehabilitation in Salt Chambers
EXPERIMENTALParticipants undergo a 16-day pulmonary rehabilitation program conducted in therapeutic salt chambers. The intervention includes general fitness, respiratory and relaxation exercises, health education. Conducted under supervision of a multidisciplinary team (physiotherapist, nurse, dietitian, physician). Sessions take place in the underground salt chambers of the "Wessel" complex (Salt Mine 'Wieliczka', Wieliczka, Poland).
Surface Rehabilitation
ACTIVE COMPARATORParticipants undergo the same 16-day pulmonary rehabilitation program as in Arm 1, but conducted in standard surface conditions without exposure to salt chamber microclimate.
Passive Stay in Salt Chambers
EXPERIMENTALParticipants attend daily 180-minutes passive sessions in therapeutic salt chambers for 16 days, without any physical exercise component.
Health education only
ACTIVE COMPARATORParticipants receive printed materials and general health education related to COPD management. No supervised exercise or microclimatic exposure is included.
Interventions
Characteristics of the underground environment in the Wieliczka sanatorium chambers: Stable climatic conditions: relative humidity ranging from 60-75%, temperature between 12.9-14.5°C; High chemical and biological air purity; Mineral content in the air: 2.7-8.1 mg/m³, consisting mainly of chloride, sodium, potassium, calcium, and fluoride ions; Air ionization: 1,200-4,700 aeroions/cm³ of air. Elevated atmospheric pressure: increased by approximately 16-20 mmHg compared to surface conditions.
30 minutes daily. Breathing exercises will include active respiratory exercises, drainage and effective coughing techniques, resistance training of the respiratory muscles, chest mobilization and relaxation exercises, breathing through pursed lips, as well as short and prolonged exhalation exercises.
30 minutes daily. General conditioning exercises will incorporate components aimed at improving overall aerobic capacity (e.g., walking-based activities, dance routines, step exercises), flexibility and coordination (e.g., stretching and balance exercises), and strength (e.g., exercises using resistance bands or dumbbells). The training will be conducted in interval, circuit, and free-form formats. Resistance levels will be individually adjusted to the patient's capacity.
30 minutes, once during the entire cycle. Relaxation training will include rest in a seated position, with dimmed lighting and calming music.
Educational materials in printed form for distribution covering the following topics: COPD - information about the disease; Breathing exercises and bronchial hygiene; Benefits of physical activity, including examples of exercises that can be performed at home.
Eligibility Criteria
You may qualify if:
- COPD diagnosis confirmed by a pulmonology specialist according to the 2025 GOLD guidelines.
- FEV1 ≥ 30% of the predicted value.
- FEV1/FVC \< 0.7 after bronchodilator administration in spirometry.
- Negative bronchodilator reversibility test.
- Voluntary written consent to participate in the study.
You may not qualify if:
- COPD exacerbation.
- Active cancer or a history of cancer within the past five years.
- Musculoskeletal disorders preventing independent movement and participation in exercise tests and training included in the study protocol.
- Recent (within six months) surgical procedure or trauma to the chest, abdomen, skull, brain, or eye area.
- Severe valvular heart disease.
- Implanted cardioverter-defibrillator.
- Diagnosed arrhythmias posing a risk of loss of consciousness.
- Acute coronary artery disease.
- Epilepsy.
- Uncontrolled arterial hypertension despite medication.
- Primary or secondary immunodeficiencies.
- Respiratory failure requiring chronic or intermittent oxygen therapy.
- Infectious diseases with fever during the experiment or within two weeks before the study.
- Claustrophobia.
- Pregnancy.
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AKF Kraków
Krakow, Małopolska, 30-009, Poland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 30, 2025
First Posted
August 14, 2025
Study Start
September 1, 2025
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
January 1, 2028
Last Updated
November 26, 2025
Record last verified: 2025-07